Losing 18 kg in Two Months with Mounjaro: Patient Story

August 2, 20260:51Patient stories

This video presents a clinical weight loss journey where a patient lost 18 kg across two months, decreasing from 108 kg to 90 kg without distressing side effects. Before starting, the patient was apprehensive about common gastrointestinal complications associated with weight loss injections. By tailoring the medication titration schedule to individual tolerance rather than rushing dose increases, appetite suppression remained steady throughout the week. The medical assessment confirmed high-quality fat loss with strong preservation of muscle tissue, proving that structured supervision prevents metabolic crashes and ensures patient comfort during intensive weight reduction.

Key points

Lost 18 kg in two months, dropping from 108 kg to 90 kg.
Minimal bothersome side effects due to personalized gradual titration.
Consistent appetite control between weekly injection doses.
Targeted fat loss while protecting lean muscle mass.

Read the full article

About this video in detail

This video tells the story of a patient who started at 108 kg and reached about 90 kg over two months. It focuses on weight loss injection results, appetite control and her concern about side effects before treatment. In her account, appetite remained controlled between injections and the experience was manageable.

The central idea is Mounjaro dose escalation. Increasing a dose quickly is not appropriate for every body, and a clinician may delay an increase according to tolerance and response. In this case, the patient reported no troublesome symptoms and described the loss as focused on fat while muscle was preserved.

The story may help people asking about appetite control without nausea or protecting muscle during dieting, but it is not a dosing plan. Read what to expect in the first Mounjaro weeks, why dose escalation is gradual, and how muscle is protected during weight loss. Her change from 108 kg to about 90 kg makes body composition and tolerance more useful questions than the headline result alone. Nahid’s account is presented as her response, leaving tolerance review with the clinician before any further treatment change.

Frequently asked questions

Gradual escalation gives the clinician time to review tolerance, appetite response and side effects before increasing treatment. The patient in the video reported a comfortable experience, but dosing is individual. See the Mounjaro dose escalation guide for the reasoning behind a slower approach.

In this video, the patient reported strong appetite control without troublesome symptoms, with some early tiredness described in her account. Responses differ, so her experience is not a promise for another person. Persistent or concerning symptoms should be reviewed with the treating clinician. Read the guide to early Mounjaro side effects.

There is no single amount that applies to everyone. The patient in this video lost about 18 kg over two months, while results depend on health, treatment, food intake, activity and response. A clinician should follow the trend and body composition rather than compare one person with a testimonial.

Muscle preservation involves suitable nutrition, appropriate activity and monitoring of fat and lean mass. The video describes muscle preservation in this patient’s case but does not provide a universal plan. An individual assessment is more useful than judging progress from scale weight alone.